Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...
18h
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
20hon MSN
Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...
Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.
Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...
On December 19, 2024, the US Food and Drug Administration (FDA) issued a new final rule titled “Food Labeling: Nutrient Content Claims; Definition ...
Health and Me on MSN1d
A New Ozempic? Researchers Develop New Weight Loss Drug That Doesn't Cause NauseaThe drug's development was funded by Novo Nordisk, the maker of popular semaglutide drugs like Ozempic and Wegovy. While ...
Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to ...
Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback